Insider · CIK 0001864650
Besthof Robert
Reports to the SEC for 1 company · WILMINGTON, DE
Transactions
7
Companies
1
Filings
3
CIK
0001864650
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-03-08 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock OptionA Award | +$261K |
| 2021-09-15 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$470K |
| 2021-08-16 | NRXPNRX Pharmaceuticals, Inc.M Exercise/Conversion | +$12.7K |
| 2021-08-16 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)C Conversion | −$20K |
| 2021-08-16 | NRXPNRX Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)A Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)A Award | — |
Recent filings
- 4Besthof Robert0000950142-22-000997SEC(opens sec.gov)
- 4Besthof Robert0000950142-21-003503SEC(opens sec.gov)
- 4Besthof Robert0000950142-21-001936SEC(opens sec.gov)
Companies
Address
C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600
WILMINGTON, DE, 19801